Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

Last year only 23% of Americans got an updated COVID-19 vaccine, according to the CDC. They recommend those six months and ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...

The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.

Vaccine skeptics have said changes were introduced to "accommodate" the shortcomings of the COVID-19 vaccines.

New COVID-19 vaccines reached about 395,000 New Yorkers, or 3.5%, so far in fall 2024, as health officials push to reverse a trend of limited uptake of the shots despite their proven effectiveness at ...